Galidesivir is a viral RNA-dependentRNApolymerase (RdRP) inhibitor and broad spectrum antiviral nucleotide.In vitro, galidesivir displays antiviral activity against a range of RNA viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses, and flaviviruses (EC50values range from 3 μM to >100 μM). Galidesivir protects against Ebola and Marburg viral infection in animal models.
Sotetsuflavone is a potent inhibitor of DENV-NS5 RdRp (Dengue virus NS5 RNA-dependentRNApolymerase) with an IC50 of 0.16 μM, is the most active compound of this series.
AZD-4573 is a selective and short-acting inhibitor of the serine threonine cyclin-dependent kinase 9, the catalytic subunit of the RNApolymerase II elongation factor positive transcription elongation factor b. It also has a potential antineoplastic activ
dmDNA31 is a rifamycin antibiotic that can inhibit the DNA-dependentRNApolymerase of bacteria and has strong bactericidal activity against Staphylococcus aureus.
Galidesivir triphosphate is a substrate for viral RNA-dependentRNApolymerase (RDRP), resulting in termination of viral RNA replication and thus serves as an antiviral. Galidesivir triphosphate inhibits HCV NS5B RNApolymerase activity and protects mice against Ebola. Galidesivir triphosphate (Immucillin-A triphosphate) is converted by the prodrug Galidesivir.